Ruo-Jing Li

3PUBLICATIONS
13CO-AUTHORS
Regenerative medicine (incl. stem cells)Molecular targetsGlycoconjugates
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Nov 27, 2023
FDA Approval Summary: Ivosidenib in Combination with Azacitidine for Treatment of Patients with Newly Diagnosed Acute Myeloid Leukemia with an IDH1 Mutation.

Ashley Woods, Kelly J Norsworthy, Xin Wang

|Feb 09, 2022
FDA Approval Summary: Belumosudil for Adult and Pediatric Patients 12 Years and Older with Chronic GvHD after Two or More Prior Lines of Systemic Therapy.

Donna Przepiorka, Robert Q Le, Alexei Ionan

|Aug 25, 2019
FDA Approval Summary: Calaspargase Pegol-mknl For Treatment of Acute Lymphoblastic Leukemia in Children and Young Adults.

Ruo-Jing Li, Runyan Jin, Chao Liu

Pageof 1